Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease.pdf		476.23 KB	Adobe PDF	Download

Authors

We aimed to compare real-life direct and indirect costs and the environmental impact of switching IBD patients from IV to SC infliximab (IFX).

Oxford University Press